Clinical Trial Update: Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV) [Phase 4]

View source ↗

Summary

A Phase 4 pharmacoeconomics study evaluating multi-dose intravenous acetaminophen (OFIRMEV) and patient outcomes following prostatectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain
• Prostate Cancer

Drugs mentioned

• Ofirmev (acetaminophen)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Prostatectomy, Pain | Phase 4 | Status: COMPLETED | Results posted: 2019-09-11